Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis

Detalhes bibliográficos
Autor(a) principal: Elsa Melanie dos Santos Nhaguilunguane
Data de Publicação: 2022
Tipo de documento: Dissertação
Idioma: eng
Título da fonte: Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
Texto Completo: https://hdl.handle.net/10216/142202
Resumo: Background: The discussion on the legalisation of consumption and commercialisation of cannabis have been a recurrent theme in multiple debates and have raised concern about the increasing numbers in consumption and related harms. This study aims to analyse the patient's perception of the risk associated with cannabis consumption in comparison with other illicit drugs. Precisely, to analyse whether patients with cannabis induced psychosis consider cannabis a health risk drug. Method: We conducted an exploratory qualitative study. For the study, twenty-one patients diagnosed with cannabis induced psychosis, followed at the psychiatric service of Centro Hospital Universitário de São João, from September 2021 to March 2022 were included. Data was collected using a questionnaire designed by the study authors. Results: The mean age of the sample is 37.4 years with 92,3% of the participants being male. Within the sample, 53,8% have an active consumption of cannabis, with weed/marijuana being the most common form of consumption (53,8%), compared to hashish (23,1%) and weed plus hashish (23,1%). Cannabis was classified by 76,2% of patients as a low-medium health risk drug, when compared to other drugs. Heroin was classified by 95,2% of the patients as a high-risk drug, 90,5% classified alcohol with medium-high risk and 95,2% classified ectasy as medium-high risk drug. Conclusion: Our findings expose that patient with cannabis induced psychosis classify cannabis as a drug with a low health risk, compared to other drugs. Even after the psychotic episode, 47,6% maintain active consumption. This can be explained by the social perception of cannabis as a drug less associated with abuse and addiction.
id RCAP_6f7d4f320a754c28a8d10fa54acb9d41
oai_identifier_str oai:repositorio-aberto.up.pt:10216/142202
network_acronym_str RCAP
network_name_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository_id_str 7160
spelling Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabisCiências médicas e da saúdeMedical and Health sciencesBackground: The discussion on the legalisation of consumption and commercialisation of cannabis have been a recurrent theme in multiple debates and have raised concern about the increasing numbers in consumption and related harms. This study aims to analyse the patient's perception of the risk associated with cannabis consumption in comparison with other illicit drugs. Precisely, to analyse whether patients with cannabis induced psychosis consider cannabis a health risk drug. Method: We conducted an exploratory qualitative study. For the study, twenty-one patients diagnosed with cannabis induced psychosis, followed at the psychiatric service of Centro Hospital Universitário de São João, from September 2021 to March 2022 were included. Data was collected using a questionnaire designed by the study authors. Results: The mean age of the sample is 37.4 years with 92,3% of the participants being male. Within the sample, 53,8% have an active consumption of cannabis, with weed/marijuana being the most common form of consumption (53,8%), compared to hashish (23,1%) and weed plus hashish (23,1%). Cannabis was classified by 76,2% of patients as a low-medium health risk drug, when compared to other drugs. Heroin was classified by 95,2% of the patients as a high-risk drug, 90,5% classified alcohol with medium-high risk and 95,2% classified ectasy as medium-high risk drug. Conclusion: Our findings expose that patient with cannabis induced psychosis classify cannabis as a drug with a low health risk, compared to other drugs. Even after the psychotic episode, 47,6% maintain active consumption. This can be explained by the social perception of cannabis as a drug less associated with abuse and addiction.2022-05-102022-05-10T00:00:00Zinfo:eu-repo/semantics/publishedVersioninfo:eu-repo/semantics/masterThesisapplication/pdfhttps://hdl.handle.net/10216/142202TID:203177347engElsa Melanie dos Santos Nhaguilunguaneinfo:eu-repo/semantics/openAccessreponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãoinstacron:RCAAP2023-11-29T14:11:21Zoai:repositorio-aberto.up.pt:10216/142202Portal AgregadorONGhttps://www.rcaap.pt/oai/openaireopendoar:71602024-03-19T23:56:39.982594Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informaçãofalse
dc.title.none.fl_str_mv Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
title Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
spellingShingle Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
Elsa Melanie dos Santos Nhaguilunguane
Ciências médicas e da saúde
Medical and Health sciences
title_short Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
title_full Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
title_fullStr Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
title_full_unstemmed Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
title_sort Perceção do risco associado ao uso de drogas em doentes com história prévia de psicose induzida por cannabis
author Elsa Melanie dos Santos Nhaguilunguane
author_facet Elsa Melanie dos Santos Nhaguilunguane
author_role author
dc.contributor.author.fl_str_mv Elsa Melanie dos Santos Nhaguilunguane
dc.subject.por.fl_str_mv Ciências médicas e da saúde
Medical and Health sciences
topic Ciências médicas e da saúde
Medical and Health sciences
description Background: The discussion on the legalisation of consumption and commercialisation of cannabis have been a recurrent theme in multiple debates and have raised concern about the increasing numbers in consumption and related harms. This study aims to analyse the patient's perception of the risk associated with cannabis consumption in comparison with other illicit drugs. Precisely, to analyse whether patients with cannabis induced psychosis consider cannabis a health risk drug. Method: We conducted an exploratory qualitative study. For the study, twenty-one patients diagnosed with cannabis induced psychosis, followed at the psychiatric service of Centro Hospital Universitário de São João, from September 2021 to March 2022 were included. Data was collected using a questionnaire designed by the study authors. Results: The mean age of the sample is 37.4 years with 92,3% of the participants being male. Within the sample, 53,8% have an active consumption of cannabis, with weed/marijuana being the most common form of consumption (53,8%), compared to hashish (23,1%) and weed plus hashish (23,1%). Cannabis was classified by 76,2% of patients as a low-medium health risk drug, when compared to other drugs. Heroin was classified by 95,2% of the patients as a high-risk drug, 90,5% classified alcohol with medium-high risk and 95,2% classified ectasy as medium-high risk drug. Conclusion: Our findings expose that patient with cannabis induced psychosis classify cannabis as a drug with a low health risk, compared to other drugs. Even after the psychotic episode, 47,6% maintain active consumption. This can be explained by the social perception of cannabis as a drug less associated with abuse and addiction.
publishDate 2022
dc.date.none.fl_str_mv 2022-05-10
2022-05-10T00:00:00Z
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
dc.type.driver.fl_str_mv info:eu-repo/semantics/masterThesis
format masterThesis
status_str publishedVersion
dc.identifier.uri.fl_str_mv https://hdl.handle.net/10216/142202
TID:203177347
url https://hdl.handle.net/10216/142202
identifier_str_mv TID:203177347
dc.language.iso.fl_str_mv eng
language eng
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv application/pdf
dc.source.none.fl_str_mv reponame:Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
instname:Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron:RCAAP
instname_str Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
instacron_str RCAAP
institution RCAAP
reponame_str Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
collection Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos)
repository.name.fl_str_mv Repositório Científico de Acesso Aberto de Portugal (Repositórios Cientìficos) - Agência para a Sociedade do Conhecimento (UMIC) - FCT - Sociedade da Informação
repository.mail.fl_str_mv
_version_ 1799135887349514240